188 related articles for article (PubMed ID: 26279299)
21. Isolation and phylogenetic analysis of HERV-K long terminal repeat cDNA in cancer cells.
Kim HS; Yi JM; Jeon SH
AIDS Res Hum Retroviruses; 2001 Jul; 17(10):987-90. PubMed ID: 11461685
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the Long Terminal Repeat of the Endogenous Retrovirus-derived microRNAs in the Olive Flounder.
Lee HE; Jo A; Im J; Cha HJ; Kim WJ; Kim HH; Kim DS; Kim W; Yang TJ; Kim HS
Sci Rep; 2019 Sep; 9(1):14007. PubMed ID: 31570746
[TBL] [Abstract][Full Text] [Related]
23. The transcriptional activity of HERV-I LTR is negatively regulated by its cis-elements and wild type p53 tumor suppressor protein.
Chang NT; Yang WK; Huang HC; Yeh KW; Wu CW
J Biomed Sci; 2007 Mar; 14(2):211-22. PubMed ID: 17151828
[TBL] [Abstract][Full Text] [Related]
24. Endogenous retrovirus HERV-I LTR family in primates: sequences, phylogeny, and evolution.
Lee JW; Kim HS
Arch Virol; 2006 Aug; 151(8):1651-8. PubMed ID: 16508704
[TBL] [Abstract][Full Text] [Related]
25. Endogenous retrovirus long terminal repeats as ready-to-use mobile promoters: the case of primate beta3GAL-T5.
Dunn CA; van de Lagemaat LN; Baillie GJ; Mager DL
Gene; 2005 Dec; 364():2-12. PubMed ID: 16112824
[TBL] [Abstract][Full Text] [Related]
26. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
Bi X; Yang L; Mancl ME; Barnes BJ
J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
[TBL] [Abstract][Full Text] [Related]
27. Functional activity of HERV-K-T47D-related long terminal repeats.
Baust C; Seifarth W; Schön U; Hehlmann R; Leib-Mösch C
Virology; 2001 May; 283(2):262-72. PubMed ID: 11336551
[TBL] [Abstract][Full Text] [Related]
28. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.
Stengel S; Fiebig U; Kurth R; Denner J
Genes Chromosomes Cancer; 2010 May; 49(5):401-11. PubMed ID: 20095041
[TBL] [Abstract][Full Text] [Related]
29. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.
Lamprecht B; Walter K; Kreher S; Kumar R; Hummel M; Lenze D; Köchert K; Bouhlel MA; Richter J; Soler E; Stadhouders R; Jöhrens K; Wurster KD; Callen DF; Harte MF; Giefing M; Barlow R; Stein H; Anagnostopoulos I; Janz M; Cockerill PN; Siebert R; Dörken B; Bonifer C; Mathas S
Nat Med; 2010 May; 16(5):571-9, 1p following 579. PubMed ID: 20436485
[TBL] [Abstract][Full Text] [Related]
30. Molecular effects of autoimmune-risk promoter polymorphisms on expression, exon choice, and translational efficiency of interferon regulatory factor 5.
Clark DN; Lambert JP; Till RE; Argueta LB; Greenhalgh KE; Henrie B; Bills T; Hawkley TF; Roznik MG; Sloan JM; Mayhew V; Woodland L; Nelson EP; Tsai MH; Poole BD
J Interferon Cytokine Res; 2014 May; 34(5):354-65. PubMed ID: 24350899
[TBL] [Abstract][Full Text] [Related]
31. NF-κB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5' Long Terminal Repeat.
Manghera M; Ferguson-Parry J; Lin R; Douville RN
J Virol; 2016 Oct; 90(20):9338-49. PubMed ID: 27512062
[TBL] [Abstract][Full Text] [Related]
32. Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions.
Gogvadze E; Stukacheva E; Buzdin A; Sverdlov E
J Virol; 2009 Jun; 83(12):6098-105. PubMed ID: 19339349
[TBL] [Abstract][Full Text] [Related]
33. Systematic identification and characterization of regulatory elements derived from human endogenous retroviruses.
Ito J; Sugimoto R; Nakaoka H; Yamada S; Kimura T; Hayano T; Inoue I
PLoS Genet; 2017 Jul; 13(7):e1006883. PubMed ID: 28700586
[TBL] [Abstract][Full Text] [Related]
34. A rare event of insertion polymorphism of a HERV-K LTR in the human genome.
Mamedov I; Lebedev Y; Hunsmann G; Khusnutdinova E; Sverdlov E
Genomics; 2004 Sep; 84(3):596-9. PubMed ID: 15498467
[TBL] [Abstract][Full Text] [Related]
35. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats.
Schön U; Seifarth W; Baust C; Hohenadl C; Erfle V; Leib-Mösch C
Virology; 2001 Jan; 279(1):280-91. PubMed ID: 11145909
[TBL] [Abstract][Full Text] [Related]
36. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a novel long terminal repeat (LTR2i_SS) in Sus Scrofa.
Lim SL; Kortschak RD; Adelson DL
Anim Genet; 2014 Jun; 45(3):367-72. PubMed ID: 24617963
[TBL] [Abstract][Full Text] [Related]
38. Retroviral safety: analyses of phylogeny, prevalence and polymorphisms of porcine endogenous retroviruses.
Niebert M; Kurth R; Tönjes RR
Ann Transplant; 2003; 8(3):56-64. PubMed ID: 15114941
[TBL] [Abstract][Full Text] [Related]
39. The phylogeny of orthoretroviral long terminal repeats (LTRs).
Benachenhou F; Blikstad V; Blomberg J
Gene; 2009 Dec; 448(2):134-8. PubMed ID: 19595747
[TBL] [Abstract][Full Text] [Related]
40. Only those genes of the KIAA1245 gene subfamily that contain HERV(K) LTRs in their introns are transcriptionally active.
Illarionova AE; Vinogradova TV; Sverdlov ED
Virology; 2007 Feb; 358(1):39-47. PubMed ID: 16997346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
